Vir Biotechnology, Inc.
VIR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $223 | $242 | $849 | $348 |
| Short-Term Investments | $682 | $1,281 | $1,553 | $360 |
| Receivables | $0 | $0 | $0 | $773 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $137 | $66 | $117 | $82 |
| Total Curr. Assets | $1,042 | $1,588 | $2,519 | $1,563 |
| Property Plant & Equip (Net) | $123 | $167 | $188 | $130 |
| Goodwill | $17 | $17 | $17 | $17 |
| Intangibles | $8 | $23 | $33 | $33 |
| Long-Term Investments | $190 | $105 | $24 | $201 |
| Tax Assets | $0 | $0 | $250 | $0 |
| Other NC Assets | $18 | $19 | -$228 | $10 |
| Total NC Assets | $356 | $331 | $283 | $391 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,399 | $1,919 | $2,802 | $1,954 |
| Liabilities | – | – | – | – |
| Payables | $5 | $6 | $6 | $7 |
| Short-Term Debt | $8 | $13 | $4 | $4 |
| Tax Payable | $0 | $0 | $15 | $6 |
| Deferred Revenue | $13 | $65 | $16 | $98 |
| Other Curr. Liab. | $94 | $91 | $470 | $226 |
| Total Curr. Liab. | $120 | $175 | $511 | $341 |
| LT Debt | $90 | $112 | $124 | $134 |
| Deferred Rev, NC | $0 | $2 | $53 | $4 |
| Deferred Tax Liab, NC | $0 | $0 | $3 | $18 |
| Other NC Liab. | $39 | $40 | $33 | $25 |
| Total NC Liab. | $129 | $153 | $213 | $181 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $98 | $125 | $128 | $137 |
| Total Liabilities | $248 | $329 | $724 | $522 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$760 | -$238 | $377 | -$139 |
| AOCI | -$2 | -$1 | -$9 | -$1 |
| Other Equity | $1,912 | $1,829 | $1,710 | $1,572 |
| Total Equity | $1,150 | $1,590 | $2,078 | $1,432 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,399 | $1,919 | $2,802 | $1,954 |
| Net Debt | -$125 | -$117 | -$721 | -$210 |